Literature DB >> 1531474

Natural cytotoxic T cells responsible for anti-CD3-induced cytotoxicity in mice.

Y Yanagita1, T Nishimura, X H Gao, T Mitomi, S Habu.   

Abstract

T cells obtained from normal mouse spleen cells showed significant cytotoxic activity against Fc receptor positive tumor cells in the presence of anti-CD3 monoclonal antibody (mAb). This activity was designated as natural cytotoxic T cell (NCT) activity and compared with natural killer (NK) activity. Considerable levels of NCT activity were detected in mouse strains with both high and low NK activity. NCT cells were distributed in both lower and higher density fractions of Percoll discontinuous density gradients, while NK cells were enriched in the lower density fraction of Percoll gradients. Moreover, NCT activity was resistant to in vivo anti-asialo GM1 treatment, in contrast to NK cells. These results indicate that NCT cells, which have different characteristics from NK cells, are present in normal, nonimmunized mouse spleen cells. Unexpectedly, CD4+ T cells sorted from normal mouse spleen T cells revealed significant NCT activity, as did CD8+ T cells. It was also demonstrated that NCT cells require the LFA-1 molecule to lyse tumor cells in the presence of anti-CD3 mAb.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531474     DOI: 10.1016/0165-2478(92)90140-j

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

1.  Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.

Authors:  Elizabeth Bolesta; Aleksandra Kowalczyk; Andrzej Wierzbicki; Cheryl Eppolito; Yutaro Kaneko; Masafumi Takiguchi; Leonidas Stamatatos; Protul A Shrikant; Danuta Kozbor
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

2.  STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.

Authors:  Takayuki Ohkuri; Arundhati Ghosh; Akemi Kosaka; Jianzhong Zhu; Maki Ikeura; Michael David; Simon C Watkins; Saumendra N Sarkar; Hideho Okada
Journal:  Cancer Immunol Res       Date:  2014-10-09       Impact factor: 11.151

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.